Elevated protein levels of B-catenin, vimentin, and BCL2 have been evidenced to inhibit apoptosis and are frequently associated with epithelial mesenchymal transition (EMT) and tumor metastasis [19–21]. This evidence concerns the gene BCL2 and neoplasm.